Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 30, 2004 Filed Apr 1, 2004 21:06 UTC |
BODNAR ANDREW GSVP, Strat & Med & Ext Affairs
|
Exercise / conversionOption (right to buy) · Derivative | 114,209 | $0.00 Strike: $12.27 | $0.00 |
DisclosureSEC source: 0000014272-04-000098 · bod246.xml · derivative · entry 7 BODNAR ANDREW G · CIK 0001213914 · SVP, Strat & Med & Ext Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 114,209 shares Expires 2004-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently Exercisable. Read SEC document |
| March 30, 2004 Filed Apr 1, 2004 21:06 UTC |
BODNAR ANDREW GSVP, Strat & Med & Ext Affairs
|
Tax withholdingCommon Stock, $0.10 par value | 19,049 | $24.22 | $461,366.78 |
DisclosureSEC source: 0000014272-04-000098 · bod246.xml · nonDerivative · entry 3 BODNAR ANDREW G · CIK 0001213914 · SVP, Strat & Med & Ext Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,811 F2 · shares: Shares withheld for payment of taxes upon exercise of stock option. Read SEC document |
| March 30, 2004 Filed Apr 1, 2004 21:06 UTC |
BODNAR ANDREW GSVP, Strat & Med & Ext Affairs
|
Tax withholdingCommon Stock, $0.10 par value | 57,871 | $24.22 | $1,401,635.62 |
DisclosureSEC source: 0000014272-04-000098 · bod246.xml · nonDerivative · entry 2 BODNAR ANDREW G · CIK 0001213914 · SVP, Strat & Med & Ext Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,860 F1 · shares: Shares withheld for payment of exercise price. Read SEC document |
| March 30, 2004 Filed Apr 1, 2004 21:06 UTC |
BODNAR ANDREW GSVP, Strat & Med & Ext Affairs
|
Exercise / conversionCommon Stock, $0.10 par value | 114,209 | $12.27 | $1,401,344.43 |
DisclosureSEC source: 0000014272-04-000098 · bod246.xml · nonDerivative · entry 1 BODNAR ANDREW G · CIK 0001213914 · SVP, Strat & Med & Ext Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2004 Filed Mar 22, 2004 21:10 UTC |
ALLEN ROBERT EDirector
|
Exercise / conversionOption (right to buy) · Derivative | 4,207 | $0.00 Strike: $15.44 | $0.00 |
DisclosureSEC source: 0000014272-04-000085 · all244.xml · derivative · entry 4 ALLEN ROBERT E · CIK 0001188466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 4,207 shares Expires 2005-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Currently Exercisable. Read SEC document |
| March 19, 2004 Filed Mar 22, 2004 21:10 UTC |
ALLEN ROBERT EDirector
|
Exercise / conversionOption (right to buy) · Derivative | 4,207 | $0.00 Strike: $13.15 | $0.00 |
DisclosureSEC source: 0000014272-04-000085 · all244.xml · derivative · entry 3 ALLEN ROBERT E · CIK 0001188466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 4,207 shares Expires 2004-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Currently Exercisable. Read SEC document |
| March 19, 2004 Filed Mar 22, 2004 21:10 UTC |
ALLEN ROBERT EDirector
|
Exercise / conversionCommon Stock, $0.10 par value | 4,207 | $15.44 | $64,956.08 |
DisclosureSEC source: 0000014272-04-000085 · all244.xml · nonDerivative · entry 2 ALLEN ROBERT E · CIK 0001188466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2004 Filed Mar 22, 2004 21:10 UTC |
ALLEN ROBERT EDirector
|
Exercise / conversionCommon Stock, $0.10 par value | 4,207 | $13.15 | $55,322.05 |
DisclosureSEC source: 0000014272-04-000085 · all244.xml · nonDerivative · entry 1 ALLEN ROBERT E · CIK 0001188466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2004 Filed Mar 17, 2004 15:37 UTC |
KARR PAUL WVP & Financial Controller
|
GrantDeferred Share Units · Derivative | 2,880.28 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000082 · kar238.xml · derivative · entry 1 KARR PAUL W · CIK 0001269198 · VP & Financial Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,880.28 Underlying: Common Stock, $0.10 par value · 2,880.28 shares Expires not disclosed F1 · shares: Consists of deferred share units accrued under the 1997 Performance Incentive Plan. F2 · derivative.exercise_date: Deferred share units are settled in shares of stock either in one lump sum payment or in installments upon the employee's termination. F2 · derivative.expiration_date: Deferred share units are settled in shares of stock either in one lump sum payment or in installments upon the employee's termination. Read SEC document |
| March 15, 2004 Filed Mar 17, 2004 15:37 UTC |
SIGAL ELLIOTSVP, Global Clin & Pharm Dev
|
GrantDeferred Share Units · Derivative | 8,519.84 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000083 · sig239.xml · derivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · SVP, Global Clin & Pharm Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,148.81 Underlying: Common Stock, $0.10 par value · 8,519.84 shares Expires not disclosed F1 · shares: Consists of deferred share units accrued under the 1997 Performance Incentive Plan. F2 · derivative.exercise_date: Deferred share units are settled in shares of stock either in one lump sum payment or in installments upon the employee's termination. F2 · derivative.expiration_date: Deferred share units are settled in shares of stock either in one lump sum payment or in installments upon the employee's termination. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:24 UTC |
ANDREOTTI LAMBERTOSVP & President, International
|
GrantOption (right to buy) · Derivative | 108,000 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0000014272-04-000064 · and232.xml · derivative · entry 2 ANDREOTTI LAMBERTO · CIK 0001208099 · SVP & President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,000 Underlying: Common Stock, $0.10 par value · 108,000 shares Expires 2014-03-01 F2 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:24 UTC |
ANDREOTTI LAMBERTOSVP & President, International
|
GrantCommon Stock, $0.10 par value | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000064 · and232.xml · nonDerivative · entry 1 ANDREOTTI LAMBERTO · CIK 0001208099 · SVP & President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,264 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:24 UTC |
BAINS HARRISON M JRVP, Tax and Treasury
|
GrantOption (right to buy) · Derivative | 25,000 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0000014272-04-000065 · bai217.xml · derivative · entry 2 BAINS HARRISON M JR · CIK 0001202282 · VP, Tax and Treasury 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock, $0.10 par value · 25,000 shares Expires 2014-03-01 F2 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:24 UTC |
BAINS HARRISON M JRVP, Tax and Treasury
|
GrantCommon Stock, $0.10 par value | 4,167 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000065 · bai217.xml · nonDerivative · entry 1 BAINS HARRISON M JR · CIK 0001202282 · VP, Tax and Treasury 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,652 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:24 UTC |
BEAR STEPHEN ESVP, Human Resources
|
GrantOption (right to buy) · Derivative | 53,333 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0000014272-04-000066 · bea218.xml · derivative · entry 3 BEAR STEPHEN E · CIK 0001199290 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,333 Underlying: Common Stock, $0.10 par value · 53,333 shares Expires 2014-03-01 F3 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:24 UTC |
BEAR STEPHEN ESVP, Human Resources
|
GrantCommon Stock, $0.10 par value | 8,889 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000066 · bea218.xml · nonDerivative · entry 1 BEAR STEPHEN E · CIK 0001199290 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,421 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:24 UTC |
BODNAR ANDREW GSVP, Strat & Med & Ext Affairs
|
GrantOption (right to buy) · Derivative | 53,333 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0000014272-04-000067 · bod219.xml · derivative · entry 5 BODNAR ANDREW G · CIK 0001213914 · SVP, Strat & Med & Ext Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,333 Underlying: Common Stock, $0.10 par value · 53,333 shares Expires 2014-03-01 F3 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:24 UTC |
BODNAR ANDREW GSVP, Strat & Med & Ext Affairs
|
GrantCommon Stock, $0.10 par value | 8,889 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000067 · bod219.xml · nonDerivative · entry 1 BODNAR ANDREW G · CIK 0001213914 · SVP, Strat & Med & Ext Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,522 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:24 UTC |
BONFIELD ANDREW R JSVP & CFO
|
GrantOption (right to buy) · Derivative | 113,333 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0000014272-04-000068 · bon220.xml · derivative · entry 3 BONFIELD ANDREW R J · CIK 0001199292 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,333 Underlying: Common Stock, $0.10 par value · 113,333 shares Expires 2014-03-01 F3 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:24 UTC |
BONFIELD ANDREW R JSVP & CFO
|
GrantCommon Stock, $0.10 par value | 18,889 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000068 · bon220.xml · nonDerivative · entry 1 BONFIELD ANDREW R J · CIK 0001199292 · SVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,889 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:24 UTC |
DIXON WENDY LCMO & Pres, Global Marketing
|
GrantOption (right to buy) · Derivative | 45,333 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0000014272-04-000069 · dix221.xml · derivative · entry 3 DIXON WENDY L · CIK 0001202283 · CMO & Pres, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,333 Underlying: Common Stock, $0.10 par value · 45,333 shares Expires 2014-03-01 F3 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:24 UTC |
DIXON WENDY LCMO & Pres, Global Marketing
|
GrantCommon Stock, $0.10 par value | 7,556 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000069 · dix221.xml · nonDerivative · entry 1 DIXON WENDY L · CIK 0001202283 · CMO & Pres, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,556 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:24 UTC |
DOLAN PETER RDirector · Chairman of the Board and CEO
|
GrantOption (right to buy) · Derivative | 500,500 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0000014272-04-000070 · dol222.xml · derivative · entry 5 DOLAN PETER R · CIK 0001199293 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,500 Underlying: Common Stock, $0.10 par value · 500,500 shares Expires 2014-03-01 F3 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:24 UTC |
DOLAN PETER RDirector · Chairman of the Board and CEO
|
GrantCommon Stock, $0.10 par value | 88,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000070 · dol222.xml · nonDerivative · entry 1 DOLAN PETER R · CIK 0001199293 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,918 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:24 UTC |
HAYDEN DONALD J JREVP and President, Americas
|
GrantOption (right to buy) · Derivative | 110,000 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0000014272-04-000071 · hay223.xml · derivative · entry 3 HAYDEN DONALD J JR · CIK 0001202285 · EVP and President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock, $0.10 par value · 110,000 shares Expires 2014-03-01 F3 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:24 UTC |
HAYDEN DONALD J JREVP and President, Americas
|
GrantCommon Stock, $0.10 par value | 18,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000071 · hay223.xml · nonDerivative · entry 1 HAYDEN DONALD J JR · CIK 0001202285 · EVP and President, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,156 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:25 UTC |
HOOPER ANTHONY CPresident US Pharmaceuticals
|
GrantOption (right to buy) · Derivative | 63,333 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0000014272-04-000072 · hoo224.xml · derivative · entry 4 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,333 Underlying: Common Stock, $0.10 par value · 63,333 shares Expires 2014-03-01 F3 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:25 UTC |
HOOPER ANTHONY CPresident US Pharmaceuticals
|
GrantCommon Stock, $0.10 par value | 10,556 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000072 · hoo224.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · President US Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,801 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:25 UTC |
HOWSON TAMAR DSVP, Corp & Bus Development
|
GrantOption (right to buy) · Derivative | 46,667 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0000014272-04-000073 · how231.xml · derivative · entry 2 HOWSON TAMAR D · CIK 0001202286 · SVP, Corp & Bus Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,667 Underlying: Common Stock, $0.10 par value · 46,667 shares Expires 2014-03-01 F2 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:25 UTC |
HOWSON TAMAR DSVP, Corp & Bus Development
|
GrantCommon Stock, $0.10 par value | 7,778 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000073 · how231.xml · nonDerivative · entry 1 HOWSON TAMAR D · CIK 0001202286 · SVP, Corp & Bus Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,862 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:25 UTC |
KARR PAUL WVP & Financial Controller
|
GrantOption (right to buy) · Derivative | 19,333 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0000014272-04-000074 · kar225.xml · derivative · entry 2 KARR PAUL W · CIK 0001269198 · VP & Financial Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,333 Underlying: Common Stock, $0.10 par value · 19,333 shares Expires 2014-03-01 F2 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:25 UTC |
KARR PAUL WVP & Financial Controller
|
GrantCommon Stock, $0.10 par value | 3,222 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000074 · kar225.xml · nonDerivative · entry 1 KARR PAUL W · CIK 0001269198 · VP & Financial Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,222 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:25 UTC |
LEUNG SANDRAVice President and Secretary
|
GrantOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0000014272-04-000075 · leu226.xml · derivative · entry 3 LEUNG SANDRA · CIK 0001199294 · Vice President and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock, $0.10 par value · 15,000 shares Expires 2014-03-01 F3 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:25 UTC |
LEUNG SANDRAVice President and Secretary
|
GrantCommon Stock, $0.10 par value | 1,667 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000075 · leu226.xml · nonDerivative · entry 2 LEUNG SANDRA · CIK 0001199294 · Vice President and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,624 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:25 UTC |
MCGOLDRICK JOHN LEVP & General Counsel
|
GrantOption (right to buy) · Derivative | 85,500 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0000014272-04-000076 · mcg227.xml · derivative · entry 3 MCGOLDRICK JOHN L · CIK 0001199295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,500 Underlying: Common Stock, $0.10 par value · 85,500 shares Expires 2014-03-01 F3 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:25 UTC |
MCGOLDRICK JOHN LEVP & General Counsel
|
GrantCommon Stock, $0.10 par value | 14,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000076 · mcg227.xml · nonDerivative · entry 1 MCGOLDRICK JOHN L · CIK 0001199295 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,943 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:25 UTC |
PALMER JAMES B D DRCSO & President, PRI
|
GrantOption (right to buy) · Derivative | 113,333 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0000014272-04-000077 · pal230.xml · derivative · entry 2 PALMER JAMES B D DR · CIK 0001213655 · CSO & President, PRI 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,333 Underlying: Common Stock, $0.10 par value · 113,333 shares Expires 2014-03-01 F2 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:25 UTC |
PALMER JAMES B D DRCSO & President, PRI
|
GrantCommon Stock, $0.10 par value | 18,889 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000077 · pal230.xml · nonDerivative · entry 1 PALMER JAMES B D DR · CIK 0001213655 · CSO & President, PRI 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,889 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:25 UTC |
SIGAL ELLIOTSVP, Global Clin & Pharm Dev
|
GrantOption (right to buy) · Derivative | 48,333 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0000014272-04-000078 · sig228.xml · derivative · entry 3 SIGAL ELLIOT · CIK 0001202294 · SVP, Global Clin & Pharm Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,333 Underlying: Common Stock, $0.10 par value · 48,333 shares Expires 2014-03-01 F3 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:25 UTC |
SIGAL ELLIOTSVP, Global Clin & Pharm Dev
|
GrantCommon Stock, $0.10 par value | 8,056 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000078 · sig228.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · SVP, Global Clin & Pharm Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,024 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:25 UTC |
SKULE JOHN L IIISVP, Corp & Envirn Affairs
|
GrantOption (right to buy) · Derivative | 43,333 | $0.00 Strike: $28.11 | $0.00 |
DisclosureSEC source: 0000014272-04-000079 · sku229.xml · derivative · entry 3 SKULE JOHN L III · CIK 0001202290 · SVP, Corp & Envirn Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,333 Underlying: Common Stock, $0.10 par value · 43,333 shares Expires 2014-03-01 F3 · derivative.exercise_date: Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Read SEC document |
| March 02, 2004 Filed Mar 4, 2004 22:25 UTC |
SKULE JOHN L IIISVP, Corp & Envirn Affairs
|
GrantCommon Stock, $0.10 par value | 7,222 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000079 · sku229.xml · nonDerivative · entry 1 SKULE JOHN L III · CIK 0001202290 · SVP, Corp & Envirn Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,122 F1 · shares: Shares consist of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Read SEC document |
| March 01, 2004 Filed Mar 2, 2004 19:43 UTC |
BAINS HARRISON M JRVP, Tax and Treasury
|
Tax withholdingCommon Stock, $0.10 par value | 1,790 | $28.04 | $50,191.60 |
DisclosureSEC source: 0000014272-04-000047 · bai215.xml · nonDerivative · entry 1 BAINS HARRISON M JR · CIK 0001202282 · VP, Tax and Treasury 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,485 F1 · kind: Shares withheld for payment of taxes upon vesting of restricted stock. Read SEC document |
| February 20, 2004 Filed Feb 23, 2004 21:52 UTC |
SIGAL ELLIOTSVP, Global Clin & Pharm Dev
|
Tax withholdingCommon Stock, $0.10 par value | 1,056 | $28.41 | $30,000.96 |
DisclosureSEC source: 0000014272-04-000045 · sig212.xml · nonDerivative · entry 1 SIGAL ELLIOT · CIK 0001202294 · SVP, Global Clin & Pharm Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,968 F1 · kind: Shares withheld for payment of taxes upon vesting of restricted stock. Read SEC document |
| February 01, 2004 Filed Feb 3, 2004 23:33 UTC |
ALLEN ROBERT EDirector
|
GrantDeferred Share Units · Derivative | 2,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000031 · all209.xml · derivative · entry 1 ALLEN ROBERT E · CIK 0001188466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,548.35 Underlying: Common Stock, $0.10 par value · 2,000 shares Expires 1988-08-08 F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. Read SEC document |
| February 01, 2004 Filed Feb 3, 2004 23:33 UTC |
CAMPBELL LEWIS BDirector
|
GrantDeferred Share Units · Derivative | 2,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000032 · cam210.xml · derivative · entry 1 CAMPBELL LEWIS B · CIK 0001176437 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,321.8 Underlying: Common Stock, $0.10 par value · 2,000 shares Expires 1988-08-08 F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. Read SEC document |
| February 01, 2004 Filed Feb 3, 2004 23:33 UTC |
COFFMAN VANCE DDirector
|
GrantDeferred Share Units · Derivative | 2,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000033 · cof202.xml · derivative · entry 1 COFFMAN VANCE D · CIK 0001193998 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,340.8 Underlying: Common Stock, $0.10 par value · 2,000 shares Expires 1988-08-08 F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. Read SEC document |
| February 01, 2004 Filed Feb 3, 2004 23:33 UTC |
FUTTER ELLEN VDirector
|
GrantDeferred Share Units · Derivative | 2,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000034 · fut203.xml · derivative · entry 1 FUTTER ELLEN V · CIK 0001206676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,651.13 Underlying: Common Stock, $0.10 par value · 2,000 shares Expires 1988-08-08 F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. Read SEC document |
| February 01, 2004 Filed Feb 3, 2004 23:33 UTC |
GERSTNER LOUIS V JRDirector
|
GrantDeferred Share Units · Derivative | 2,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000035 · ger204.xml · derivative · entry 1 GERSTNER LOUIS V JR · CIK 0001180445 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,150.37 Underlying: Common Stock, $0.10 par value · 2,000 shares Expires 1988-08-08 F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. Read SEC document |
| February 01, 2004 Filed Feb 3, 2004 23:34 UTC |
GLIMCHER LAURIE H MDDirector
|
GrantDeferred Share Units · Derivative | 2,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000014272-04-000036 · gli205.xml · derivative · entry 1 GLIMCHER LAURIE H MD · CIK 0001189295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,454.57 Underlying: Common Stock, $0.10 par value · 2,000 shares Expires 1988-08-08 F1 · derivative.exercise_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. F1 · derivative.expiration_date: Deferred share units are settled in cash either on a specified date in the future or following the cessation of the reporting person's service as a director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.